Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
20 Oct 2017 03:05 PM
RNS
Notice of AGM
17 Oct 2017 07:00 AM
RNS
ANGLE: 7th Peer Reviewed Publication On Parsortix
12 Oct 2017 07:00 AM
RNS
Proposed further subscription for £2.8 million
09 Oct 2017 07:02 AM
RNS
CTCs harvested with Parsortix grown in laboratory
09 Oct 2017 07:01 AM
RNS
Potential new analytical protocol using Parsortix
09 Oct 2017 07:00 AM
RNS
Parsortix Showcased at CTC Conference
05 Oct 2017 11:46 AM
RNS
Results of Fundraising
05 Oct 2017 07:00 AM
RNS
Acquisition and Fundraising
13 Sep 2017 05:36 PM
RNS
Holding(s) in Company
13 Sep 2017 07:00 AM
RNS
Exclusive worldwide option over megakaryocyte IP
11 Sep 2017 07:00 AM
RNS
Co-Marketing Partnership with QIAGEN
05 Sep 2017 07:00 AM
RNS
Change of Adviser
04 Sep 2017 07:00 AM
RNS
New Research with Parsortix
27 Jul 2017 07:00 AM
RNS
Preliminary Results
20 Jul 2017 01:00 PM
RNS
Preclinical Study Presented At Tumor Boston Summit
06 Jul 2017 10:05 AM
RNS
Notice of Results
04 Jul 2017 07:00 AM
RNS
Successful Headline Data in Ovarian Cancer Studies
15 Jun 2017 07:00 AM
RNS
Parsortix breakthrough in prostate cancer
05 Jun 2017 07:00 AM
RNS
Success with Parsortix in Colorectal Cancer
03 May 2017 07:00 AM
RNS
Business Update
04 Apr 2017 07:00 AM
RNS
Holding(s) in Company
03 Apr 2017 07:00 AM
RNS
Parsortix enables analysis in head and neck cancer
30 Mar 2017 07:00 AM
RNS
Prostate Cancer Update
13 Feb 2017 07:00 AM
RNS
Selected for European Cancer ID Programme
26 Jan 2017 07:01 AM
RNS
Interim Evaluation of Ovarian Cancer Study
26 Jan 2017 07:00 AM
RNS
Interim Results
04 Jan 2017 07:00 AM
RNS
Notice of Results
28 Nov 2016 07:00 AM
RNS
ISSUE OF SHARE OPTIONS
24 Nov 2016 02:48 PM
RNS
Result of GM
04 Nov 2016 07:00 AM
RNS
Barts Research Supports Potential Use of Parsortix
01 Nov 2016 07:00 AM
RNS
Notice of GM
27 Oct 2016 07:00 AM
RNS
Director's share purchase
07 Oct 2016 11:57 AM
RNS
Holding(s) in Company
04 Oct 2016 04:35 PM
RNS
Result of AGM
30 Sep 2016 07:00 AM
RNS
Research published in Clinical Chemistry
19 Sep 2016 11:14 AM
RNS
Issue of Equity
09 Sep 2016 04:12 PM
RNS
Annual Report and Accounts and Notice of AGM
04 Aug 2016 07:00 AM
RNS
MD Anderson Cancer Center poster presentation
02 Aug 2016 03:37 PM
RNS
Edison issues ADR update on Angle
28 Jul 2016 07:00 AM
RNS
Use of Parsortix in GANNET53 drug trial
28 Jul 2016 07:00 AM
RNS
Preliminary Results
27 Jul 2016 07:00 AM
RNS
Initiation of 200 patient US ovarian cancer study
19 Jul 2016 07:00 AM
RNS
Initiation of European ovarian cancer study
15 Jul 2016 07:00 AM
RNS
Notice of Results
15 Jul 2016 07:00 AM
RNS
Parsortix gaining traction at EACR Conference
01 Jun 2016 03:04 PM
RNS
Holding(s) in Company
31 May 2016 04:36 PM
RNS
Holding(s) in Company
27 May 2016 03:12 PM
RNS
Edison issues research update on Angle
25 May 2016 07:00 AM
RNS
Cancer Research UK Contract
25 May 2016 07:00 AM
RNS
Placing

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, Angle listed on LSE in 2004 under the ticker AGL.

UK 100

Latest directors dealings